UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

________________________________________________

FORM 8-K

________________________________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~December~~January 228, ~~2025~~2026

________________________________________________

Celestica Inc.

(Exact name of registrant as specified in its charter)
________________________________________________


Ontario, Canada	001-14832	98-0185558
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)


5140 Yonge Street, Suite 1900						M2N 6L7
Toronto, Ontario, Canada						(Zip Code)
(Address of principal executive officers)

(416) 448-2211

(Registrant's telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

________________________________________________

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


			☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


			☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


			☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


			☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Name of each exchange on which registered

Common Shares without par value

CLS

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 52.02. ~~Departure~~Results of ~~Directors~~Operations orand ~~Certain~~Financial ~~Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers~~Condition.

On ~~December~~January 228, ~~2025~~2026, Celestica Inc. (the “"Company”") ~~was~~issued ~~informed~~a bypress ~~Dr.~~release ~~Luis~~and ~~Müller~~will ofhold ~~his~~a ~~intention~~conference tocall ~~resign~~on ~~from~~January ~~the Board of Directors (the “Board”)~~29, as2026 ~~well~~regarding asits ~~from~~financial ~~his~~results ~~roles~~for ~~as Chair of~~ the ~~Audit~~quarter ~~Committee~~ and ~~member~~full ofyear ~~other~~ended ~~Board committees~~December 31, ~~effective~~2025. atA ~~the~~copy ~~conclusion~~ of the ~~regularly~~press ~~scheduled~~release ~~meeting on January 28, 2026. Dr. Müller’s decision to resign~~ is ~~for~~furnished ~~personal~~as ~~reasons~~Exhibit ~~in order to focus on other professional commitments and is not due to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices~~99.1 ~~Dr. Müller will continue~~ to ~~serve~~this ~~in his current capacities and remain fully engaged through the effective date of his resignation~~report.

InThe ~~connection~~information furnished with Drthis Item 2.02, ~~Müller’s~~including ~~planned~~Exhibit ~~transition~~99.1, ~~the~~shall ~~Board~~not ~~has~~be ~~appointed~~deemed ~~the~~"filed" ~~current~~for ~~member~~purposes of ~~the~~Section ~~Board~~18 ~~Mr.~~of ~~Amar~~the ~~Maletira~~Securities asExchange ~~Chair~~Act of ~~the Audit Committee~~1934, ~~effective~~as ~~upon~~amended ~~Dr.~~(the ~~Müller’s~~"Exchange ~~resignation on January 28~~Act"), ~~2026.~~or ~~Mr.~~otherwise ~~Maletira~~subject ~~has~~to ~~over~~the 25liabilities ~~years~~ of ~~broad~~that ~~public~~section, ~~company~~nor ~~business,~~shall ~~strategic~~it ~~and~~be ~~finance~~deemed ~~leadership~~incorporated inby ~~numerous~~reference ~~enterprise~~into ~~technology~~any ~~industries,~~other ~~including~~filing ~~holding~~under ~~various~~the ~~roles~~Securities asAct aof ~~Chief~~1933, ~~Financial~~as ~~Officer~~amended, ~~and~~or the ~~Board~~Exchange ~~has~~Act, ~~determined~~except ~~that~~as ~~Mr.~~expressly ~~Maletira~~set ~~possesses~~forth ~~the~~by ~~financial~~specific ~~expertise~~reference ~~appropriate~~in ~~for~~such ~~service~~a ~~as Chair of the Audit Committee~~filing.

Item 9.01. Financial Statements and Exhibits.

Exhibit No.			Description
99.1			Press Release of the Company dated January 28, 2026
104			Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	CELESTICA INC.
Date: December 5, 2025
Date: January 28, 2026
	By:	/s/ Douglas Parker
		Name: Douglas Parker
		Title: Chief Legal Officer and Corporate Secretary

Filing Compare · CELESTICA INC